FDA Approval Insights: Pirtobrutunib in Previously Treated C

Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma.

Related Keywords

Boston , Massachusetts , United States , Dana Farber Cancer Institute , Ashling Wahner , Matthews Davids , Eli Lilly , Twitter , Harvard Medical School , Linkedin , Clinical Research , Center At Dana Farber Cancer Institute , Facebook , Live On Air , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , Fda Approval Of Pirtobrutinib , Patients With Previously Treated Chronic Lymphocytic Leukemia Small Lymphoma , D , Msc ,